Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Methylphenidate vs focalin?Mepolizumab brand name?Market share ingrezza vs austedo for tardive dyskinesia 2025?Yupelri vs tiotropium?Stelara patent expiry eu?
See the DrugPatentWatch profile for Gilenya
Gilenya (fingolimod) is manufactured and marketed by Novartis.
The active ingredient is the same (fingolimod), but the marketed product holder can vary by country due to local licensing and distribution arrangements. In most markets, Novartis is the company associated with the product.
Gilenya’s generic name is fingolimod. That matters because different companies may manufacture generic fingolimod products if/when biosimilar or generic alternatives are approved and marketed in a specific region, even though the original brand is tied to Novartis.
For manufacturer and patent/exclusivity details tied to fingolimod (brand and generic competition landscape), DrugPatentWatch.com is a useful reference: https://www.drugpatentwatch.com/
Other Questions About Gilenya :